Capital Market Strategies »

Vertex Pharmaceuticals Incorporated shares owned by Capital Market Strategies

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Capital Market Strategies from 13F filings

Historical chart of Capital Market Strategies investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Capital Market Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Capital Market Strategies

Quarter filed Position value Share count Share price at filing
2024-03-31 $484k 1.2k 418.01
2023-12-31 $387k 950 406.89
2023-09-30 $332k 962 345.15
2023-06-30 $309k 878 351.91
2022-12-31 $251k 870 288.78
2022-09-30 $252k 870 289.66
2022-06-30 $245k 870 281.61
2022-03-31 $227k 870 260.92

More positions owned by Capital Market Strategies

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
First Bank (FRBA)
Ishares Tr Fltg Rate Nt Etf (FLOT)
Invesco Exchange Traded Fd T Ftse Rafi 1000 (PRF)
Invesco Exchange Traded Fd T S&p500 Eql Tec (RSPT)
Ishares Tr Core S&p Ttl Stk (ITOT)
Eli Lilly & Co. (LLY)
Home Depot (HD)
Etf Opportunities Trust Applied Fina Val (VSLU)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Abbvie (ABBV)
Costco Wholesale Corporation (COST)
Schwab Strategic Tr Us Dividend Eq (SCHD)

View all positions for Capital Market Strategies

Top funds holding Vertex Pharmaceuticals Incorporated

Vanguard Group
BlackRock
FMR
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Wellington Management Company
Jennison Associates
T. Rowe Price Associates
Amundi
Morgan Stanley
Loomis, Sayles and
Massachusetts Financial Services
Bank of America Corporation
Henderson Group

View all funds holding Vertex Pharmaceuticals Incorporated